Elizabeth K Sage

Elizabeth K Sage

UNVERIFIED PROFILE

Are you Elizabeth K Sage?   Register this Author

Register author
Elizabeth K Sage

Elizabeth K Sage

Publications by authors named "Elizabeth K Sage"

Are you Elizabeth K Sage?   Register this Author

11Publications

350Reads

44Profile Views

Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma.

Lung Cancer 2019 01 5;127:164-166. Epub 2018 Dec 5.

Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University Street, London, WC1E 6JF, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183069
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.12.004DOI Listing
January 2019

Genetically modified mesenchymal stromal cells in cancer therapy.

Cytotherapy 2016 11;18(11):1435-1445

Lungs for Living Research Centre, UCL Respiratory, Rayne Institute, University College London, London, United Kingdom; Department of Thoracic Medicine, University College London Hospital, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2016.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082580PMC
November 2016

Combined cell-gene therapy for lung cancer: rationale, challenges and prospects.

Expert Opin Biol Ther 2016 07 3;16(7):853-7. Epub 2016 Jun 3.

a Lungs for Living Research Centre, UCL Respiratory , University College London, Rayne Institute , London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2016.1188074DOI Listing
July 2016

Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy.

Cytotherapy 2016 07;18(7):860-9

Lungs for Living Research Centre, UCL Respiratory, Division of Medicine, University College London, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2016.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906234PMC
July 2016

Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy.

Cytotherapy 2015 Jul 14;17(7):885-96. Epub 2015 Apr 14.

Lungs for Living Research Centre, UCL Respiratory, Division of Medicine, University College London, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2015.03.603DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503823PMC
July 2015

Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ.

J Breast Cancer 2012 Sep 28;15(3):273-82. Epub 2012 Sep 28.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. ; Department of Medicine, Harvard Medical School, Boston, USA. ; Department of Biomedical Engineering, Tufts University, Medford, USA.

View Article

Download full-text PDF

Source
https://synapse.koreamed.org/DOIx.php?id=10.4048/jbc.2012.15
Publisher Site
http://dx.doi.org/10.4048/jbc.2012.15.3.273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468780PMC
September 2012

Mesenchymal stem cells as vectors for lung disease.

Proc Am Thorac Soc 2008 Aug;5(6):711-6

Centre of Respiratory Research, Rayne Building, University College London, 5 University Street, London WC1E 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/pats.200801-009AWDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643224PMC
August 2008